New research presented at the ESTRO 37 conference from two large international trials, shows that intracavitary and interstitial brachytherapy is safe and does not increase the risk of ureteral stricture in cervical cancer patients. Until now, there have been concerns that brachytherapy might increase the risk of this serious, sometimes life-threatening complication, although the treatment itself is associated with better survival.
Older adults who take an antioxidant that specifically targets mitochondria see age-related changes in blood vessels reverse by the equivalent of 15 to 20 years within six weeks, a new study shows.
For more than a third of children living with epilepsy, the currently approved medications do not stop their seizures. Researchers at the Cumming School of Medicine have developed a new drug screening method to discover drugs to treat epilepsy.
A University of Kansas research effort has resulted in a low-cost, reliable blood test that uses a small plastic chip about the size of a credit card that can deliver the same diagnostic information as a bone biopsy -- but using a simple blood draw instead.
An analysis of elderly patients treated in a phase II trial of radiotherapy combined with chemotherapy in non-small cell lung cancer has shown that they were less likely to benefit than younger patients if the two treatments were given at the same time. The study is presented at ESTRO37 -- Europe's largest radiation oncology conference.
A large proportion of malaria patients in endemic countries in Africa are likely to receive doses of malaria medicine that are too low to offer effective treatment, according to new research presented at the MIM Conference taking place in Dakar this week. Researchers found that an estimated 21.3 million people -- or 24 percent of all confirmed malaria cases--were at risk of being prescribed inadequate doses of artemisinin-based combination therapy (ACTs), the frontline treatment against Plasmodium falciparum malaria.
Impoverished female farm workers infected with intestinal parasites known as hookworms saw significant improvements in physical fitness when they were treated with a low-cost deworming drug. The benefits were seen even in those with low level infections, according to a study co-authored by researchers at Yale and the nonprofit company InnovationsCZ.
A preliminary study suggests that an investigational drug may help increase protein levels in babies with spinal muscular atrophy. The open-label study is released today and will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21-27, 2018.
Despite the great successes of targeted cancer drugs and the promise of novel immunotherapies, the vast majority of people diagnosed with cancer are still first treated with chemotherapy. Now a new study by UCSF researchers using techniques drawn from computational biology could make it much easier for physicians to use the genetic profile of a patient's tumor to pick the chemotherapy treatment with the fewest side effects and best chance of success.
A blood test to measure the levels of two proteins in plasma that are common predictors of lung cancer was 98 percent effective in a multicenter clinical trial at distinguishing benign from malignant lung nodules when combined with a patient's clinical characteristics to form an integrated classifier. These results were reported by a team of investigators at the Medical University of South Carolina in an article in Chest.